Citations
174
87.0 per year
Published
2023
Early treatment with pegylated interferon lambda for Covid-19
New England Journal of Medicine•2023
Authors
G Reis, EAS Moreira Silva, KCM Silva, LJ Thabane, AC Ferreira, VEG de Souza-Campos, AP de Almeida, A Nogueira, EDS Callegari, AD de Figueiredo Neto, PS Menezes de Sá, KK Shinjo, G Keepanasseril, S Shuaib, JI Forrest, JH Park, CS Wiens, CM Guo, K Thorlund, EJ Mills, ...
COVID-19
Abstract
The efficacy of a single dose of pegylated interferon lambda in preventing clinical events among outpatients with acute symptomatic coronavirus disease 2019 (Covid-19) is unclear.
Related Publications
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
The Lancet Global Health • 2022
The Lancet
COVID-19
Effect of early treatment with ivermectin among patients with Covid-19
New England Journal of Medicine • 2022
COVID-19
Ivermectin
A real-time dashboard of clinical trials for COVID-19
The Lancet Digital Health • 2020
The Lancet
COVID-19